Insmed is a research-driven biopharmaceutical company with broad expertise in and innovative approaches to the development of protein-based therapeutics, and efficiently moving product candidates through the regulatory approval process.
Insmed also has a proprietary protein drug development program that targets significant unmet medical needs in the neuromuscular therapeutic area.
